Lumature Wealth Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5
Closed -$118 397
2023
Q1
$118 Buy
+5
New +$134 ﹤0.01% 383
2022
Q4
Sell
-37
Closed -$1K 398
2022
Q3
$1K Sell
37
-10
-21% -$302 ﹤0.01% 382
2022
Q2
$2K Hold
47
﹤0.01% 381
2022
Q1
$2K Sell
47
-4
-8% -$137 ﹤0.01% 387
2021
Q4
$2K Sell
51
-13
-20% -$423 ﹤0.01% 384
2021
Q3
$2K Sell
64
-3
-4% -$96 ﹤0.01% 387
2021
Q2
$2K Buy
+67
New +$2.21K ﹤0.01% 362

Other funds holding OGN

Lumature Wealth Partners's OGN Position: Q2 2023 in Review

Lumature Wealth Partners sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 5 shares — an estimated $118 sold.

Lumature Wealth Partners first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $2K in Q2 2022. 728 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Lumature Wealth Partners reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Lumature Wealth Partners sold 5 Organon & Co shares in Q2 2023, an estimated $118.
  • Lumature Wealth Partners first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Lumature Wealth Partners's Organon & Co position peaked at $2K in Q2 2022.
  • 728 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.